SC
BIO icon

Steph & Co’s Bio-Rad Laboratories Class A BIO Stock Holding History

Steph & Co’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-244
Closed -$139K – 237
2021
Q1 		$139K Hold
244
– – 0.1% 120
2020
Q4 		$142K Sell
244
-54
-18% -$30.8K 0.11% 115
2020
Q3 		$154K Sell
298
-82
-22% -$41.5K 0.14% 88
2020
Q2 		$172K Sell
380
-70
-16% -$30.9K 0.17% 64
2020
Q1 		$158K Buy
450
+56
+14% +$20.6K 0.18% 64
2019
Q4 		$146K Buy
+394
New +$139K 0.12% 98

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Steph & Co's BIO Position: Q2 2021 in Review

Steph & Co sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2021, closing a stake of 244 shares — an estimated $139K sold.

Steph & Co first reported a position in BIO in Q4 2019 and held it in 6 quarters. The position peaked at $172K in Q2 2020. 509 funds tracked by Wall St. Rank hold BIO as of Q2 2021.

  • Steph & Co reported no remaining Bio-Rad Laboratories Class A position as of Q2 2021 after selling out during the quarter.
  • Steph & Co sold 244 Bio-Rad Laboratories Class A shares in Q2 2021, an estimated $139K.
  • Steph & Co first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 6 quarters.
  • Steph & Co's Bio-Rad Laboratories Class A position peaked at $172K in Q2 2020.
  • 509 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2021.

Based on Steph & Co's 13F filing for Q2 2021, filed 27 Jul 2021.